Lauren Merendino
Chief Commercial Officer · 3 filings · Latest: Apr 23, 2026
Day One Biopharmaceuticals, Inc.
| Ticker | Owner | Relationship | Date | Transaction | Cost | #Shares | Value ($) | #Shares Total | SEC Filing |
|---|---|---|---|---|---|---|---|---|---|
DAWN | Lauren Merendino | Chief Commercial Officer | Feb 17, 2026 | Sale | $11.60 | 5,814 | $67.4K | 60,157 | |
DAWN | Lauren Merendino | Chief Commercial Officer | Feb 15, 2026 | Option Exercise | — | 15,162 | — | 65,971 | |
DAWN | LAUREN MERENDINO | — | Feb 17, 2026 | Proposed Sale | $11.60 | 5,814 | $67.4K | — | |
DAWN | LAUREN MERENDINO | — | Nov 17, 2025 | Proposed Sale | $8.91 | 3,726 | $33.2K | — | |
DAWN | LAUREN MERENDINO | — | May 16, 2025 | Proposed Sale | $6.26 | 3,927 | $24.6K | — |